Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)A Study to Investigate Safety and Tolerability of NDX-3315 and NDX-3324 in Healthy Participants and Patients With Eosinophilic Esophagitis
- First Posted Date
- 2023-03-07
- Last Posted Date
- 2025-08-11
- Lead Sponsor
- NexEos Diagnostics, Inc.
- Target Recruit Count
- 34
- Registration Number
- NCT05757856
- Locations
- 🇺🇸
Northwestern Univerisity, Chicago, Illinois, United States
🇺🇸University of Pennsylvania, Philadelphia, Pennsylvania, United States
🇺🇸University of Utah, Salt Lake City, Utah, United States
News
No news found